Sponsor Pipeline

Chengdu SciMount Pharmatech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-24 NCT07726342 SMP-656 for HER2-Positive Advanced Breast Cancer Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07726342 SMP-656 for HER2-Positive Advanced Breast Cancer HER2-positive Breast Cancer Not Yet Recruiting
Disease Areas
Breast Cancer (1) HER2-Positive Breast Cancer (1)
Get alerts when Chengdu SciMount Pharmatech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free